DekaBank Deutsche Girozentrale’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $444K | Hold |
30,000
| – | – | ﹤0.01% | 1006 |
|
2025
Q1 | $580K | Hold |
30,000
| – | – | ﹤0.01% | 946 |
|
2024
Q4 | $514K | Hold |
30,000
| – | – | ﹤0.01% | 1003 |
|
2024
Q3 | $418K | Hold |
30,000
| – | – | ﹤0.01% | 1045 |
|
2024
Q2 | $257K | Hold |
30,000
| – | – | ﹤0.01% | 1116 |
|
2024
Q1 | $230K | Hold |
30,000
| – | – | ﹤0.01% | 1133 |
|
2023
Q4 | $280K | Buy |
+30,000
| New | +$280K | ﹤0.01% | 1147 |
|
2023
Q2 | – | Sell |
-56,400
| Closed | -$1.24M | – | 1330 |
|
2023
Q1 | $1.24M | Hold |
56,400
| – | – | ﹤0.01% | 825 |
|
2022
Q4 | $1.19M | Hold |
56,400
| – | – | ﹤0.01% | 835 |
|
2022
Q3 | $1.4M | Hold |
56,400
| – | – | ﹤0.01% | 797 |
|
2022
Q2 | $1.4M | Hold |
56,400
| – | – | ﹤0.01% | 799 |
|
2022
Q1 | $1.42M | Hold |
56,400
| – | – | ﹤0.01% | 834 |
|
2021
Q4 | $1.69M | Sell |
56,400
-13,100
| -19% | -$392K | ﹤0.01% | 813 |
|
2021
Q3 | $1.79M | Buy |
69,500
+55,000
| +379% | +$1.41M | 0.01% | 742 |
|
2021
Q2 | $213K | Hold |
14,500
| – | – | ﹤0.01% | 1204 |
|
2021
Q1 | $351K | Hold |
14,500
| – | – | ﹤0.01% | 1085 |
|
2020
Q4 | $386K | Sell |
14,500
-700
| -5% | -$18.6K | ﹤0.01% | 1075 |
|
2020
Q3 | $280K | Buy |
+15,200
| New | +$280K | ﹤0.01% | 1005 |
|
2019
Q4 | – | Sell |
-15,800
| Closed | -$188K | – | 1224 |
|
2019
Q3 | $188K | Sell |
15,800
-15,800
| -50% | -$188K | ﹤0.01% | 862 |
|
2019
Q2 | $635K | Buy |
31,600
+12,200
| +63% | +$245K | ﹤0.01% | 882 |
|
2019
Q1 | $575K | Buy |
19,400
+3,600
| +23% | +$107K | ﹤0.01% | 883 |
|
2018
Q4 | $352K | Sell |
15,800
-3,600
| -19% | -$80.2K | ﹤0.01% | 889 |
|
2018
Q3 | $575K | Sell |
19,400
-500
| -3% | -$14.8K | ﹤0.01% | 903 |
|
2018
Q2 | $515K | Hold |
19,900
| – | – | ﹤0.01% | 899 |
|
2018
Q1 | $434K | Sell |
19,900
-400
| -2% | -$8.72K | ﹤0.01% | 888 |
|
2017
Q4 | $472K | Hold |
20,300
| – | – | ﹤0.01% | 832 |
|
2017
Q3 | $472K | Hold |
20,300
| – | – | ﹤0.01% | 838 |
|
2017
Q2 | $394K | Hold |
20,300
| – | – | ﹤0.01% | 866 |
|
2017
Q1 | $366K | Sell |
20,300
-1,700
| -8% | -$30.7K | ﹤0.01% | 786 |
|
2016
Q4 | $420K | Buy |
22,000
+1,700
| +8% | +$32.5K | ﹤0.01% | 690 |
|
2016
Q3 | $444K | Hold |
20,300
| – | – | ﹤0.01% | 687 |
|
2016
Q2 | $364K | Buy |
20,300
+4,700
| +30% | +$84.3K | ﹤0.01% | 742 |
|
2016
Q1 | $209K | Sell |
15,600
-2,600
| -14% | -$34.8K | ﹤0.01% | 844 |
|
2015
Q4 | $358K | Buy |
18,200
+600
| +3% | +$11.8K | ﹤0.01% | 755 |
|
2015
Q3 | $357K | Buy |
17,600
+1,400
| +9% | +$28.4K | ﹤0.01% | 754 |
|
2015
Q2 | $537K | Buy |
16,200
+3,800
| +31% | +$126K | 0.01% | 688 |
|
2015
Q1 | $297K | Buy |
+12,400
| New | +$297K | ﹤0.01% | 824 |
|